CAMP4 Therapeutics Corp. (CAMP)
4.15
-0.02
(-0.48%)
USD |
NASDAQ |
Sep 22, 16:00
4.15
0.00 (0.00%)
After-Hours: 20:00
CAMP4 Therapeutics Shareholders Equity (Quarterly) : -0.693M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.693M |
| March 31, 2026 | 30.90M |
| December 31, 2025 | 47.70M |
| September 30, 2025 | 58.67M |
| June 30, 2025 | 39.99M |
| March 31, 2025 | 51.57M |
| Date | Value |
|---|---|
| December 31, 2024 | 63.14M |
| September 30, 2024 | 3.172M |
| June 30, 2024 | 15.03M |
| March 31, 2024 | |
| December 31, 2023 | 38.42M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| MannKind Corp. | -67.20M |
| Ocugen, Inc. | -16.56M |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 93.43M |
| Total Liabilities (Quarterly) | 94.12M |
| Debt to Equity Ratio | -3.423 |
| Current Ratio | 4.703 |
| Net Debt Paydown Yield | 0.49% |